Clinical Trial CTSUTHOC30607-M

Title

ARandomized, Phase III, Double-Blind Placebo-Controlled Trial of Sunitinib as Maintenance Therapy in Non-Progressing Patients following an Initial Four Cycles of Platinum-Based Combination Chemotherapy in Advanced, Stage IIIB/IV Non-Small Cell Lung Cancer

Principal Investigator(s)

John Murray

Details

  • Protocol No. CTSUTHOC30607-M
  • Open Date: 02/17/2010
  • Staging: Phase III
  • Age Group: Adults
  • Scope: National
  • Objective:
  • Disease Sites:
  • Therapies: Molecular Targeted Agents / Immunotherapy / Biologics
  • Drugs: None Specified
  • Participating Institutions: Meharry Medical College
  • Secondary Protocol No: Not Specified

Description

Eligibility

Learn More

You do not have JavaScript enabled. This site works better with JavaScript turned on.